Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AAV, aberrant, absence, acid, acute, add, affirmative, agent, alleging, antagonist, asserted, asserting, assigned, award, balloon, Bank, bankruptcy, begun, benchmark, beta, biotechnology, bone, bunionectomy, cadaver, carbon, Carthronix, cartilage, casualty, CDC, Chase, Chemogenetic, commonly, Complaint, confer, confronting, corticosteroid, coupled, customizability, decade, declaration, degeneration, denervation, detail, diminished, dioxide, disability, disagreement, District, double, EC, electrical, entry, factor, Fargo, fibrillation, flexibility, floor, forefront, forma, fraction, framework, frequency, funapide, Genascence, great, guarantor, hemodynamically, Houston, hyaluronic, hydrogel, IA, illustrate, inability, incidence, incorporating, indirectly, infancy, inflammation, inhibitor, insolvency, interactive, interleukin, interpretation, introduction, JP, laboratory, lender, lessening, lien, life, lifetime, loan, longer, magnitude, mandatory, matrix, mediating, metabolized, microsphere, mission, mL, Morgan, neuronal, Neuropathic, Nevada, notification, numerator, NYFRB, occasion, Omicron, Orthopaedic, parent, peptide, pharmacy, pivotal, placebo, plasma, platelet, PLGA, pMVL, poly, post, predetermined, premarket, prepayment, prevalence, Prime, prioritization, prioritized, pro, protein, protest, proven, PRP, RDF, receptor, Recognition, recurrence, redefine, Reform, regulation, reimbursement, remitted, Removal, renamed, repayment, requesting, rescue, resell, rich, role, ROU, shortly, shoulder, slowly, SOFR, steroid, storm, strength, sublease, swelling, TA, tachycardia, thereon, thermosensitive, traditional, transforming, trustee, uncured, underlying, unstable, vehicle, ventricular, water, Week, Woburn, worse, York
Removed:
adequacy, adult, ankle, annually, assume, augmentation, automatically, Bio, breast, broad, calculating, cardiac, clear, computed, conclude, conservative, contingency, custom, decision, deductible, deemed, demonstrate, Department, DePuy, desire, effectively, emergency, empower, enacted, enactment, enrolled, enrolling, evidence, evolution, exacerbate, expressly, extinguishment, failed, fewer, flat, foot, forward, France, franchise, functional, FUSION, gain, Germany, grew, grow, Hamburg, headquartered, hygiene, Iceland, identified, impaired, implemented, infrastructure, inquiry, instrument, intent, issuer, Italy, journey, junior, Justice, labeling, Lastly, launch, license, Liechtenstein, lifestyle, lift, manage, mandated, manner, manufactured, member, methodology, mild, minimizing, mistake, month, NDA, negatively, netted, nonconvertible, Norway, offsetting, outreach, par, partial, partnership, pectoral, personal, pertaining, postoperative, predicated, preferred, prepare, prescription, prespecified, presurgical, privately, procedural, pronouncement, rank, reach, realizable, reclassified, recovery, recur, regimen, reluctant, remained, remote, renew, reopening, resulted, reviewed, rolling, safely, schedule, securing, Simplifying, solution, Spain, spinal, strict, STRIDE, structurally, structured, subordinated, synergy, target, TELA, Topic, unconsolidated, utilized, vaccinated, viscosupplementation, young
Filing tables
Filing exhibits
Related press release
Associated PCRX transcripts
PCRX similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this Quarterly Report on Form 10-Q of Pacira BioSciences, Inc. for the quarter ended March 31, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira BioSciences, Inc. at the dates and for the periods indicated.
| Date: | May 4, 2022 | /s/ DAVID STACK | ||||||
| David Stack | ||||||||
| Chief Executive Officer and Chairman | ||||||||
| (Principal Executive Officer) | ||||||||
| Date: | May 4, 2022 | /s/ CHARLES A. REINHART, III | ||||||
| Charles A. Reinhart, III | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial Officer) | ||||||||